Borstnar, S. (2022) “Ribociclib plus letrozole in patients with hormone receptor‐positive, HER2‐negative advanced breast cancer with no prior endocrine therapy: subgroup analysis from the phase 3b CompLEEment‐1 trial: Subgroup analysis of the CompLEEment‐1 trial”, Radiology and Oncology, 56(2), pp. 238–247. Available at: https://www.radioloncol.com/index.php/ro/article/view/3866 (Accessed: 24 July 2026).